News

AddToAny

Google+ Facebook Twitter Twitter

On-chip PCR could speed diagnosis in pandemics

Reverse transcription-polymerase chain reaction (RT-PCR) has been the gold standard for diagnosis during the COVID-19 pandemic.

However, the PCR portion of the test requires bulky, expensive machines and takes about an hour to complete.

Scientists have now developed a plasmofluidic chip that can perform PCR in about eight minutes, which could speed diagnosis during current and future pandemics.

Currently, RT-PCR is the most sensitive and reliable diagnostic method, but because the PCR portion of the test requires 30–40 cycles of heating and cooling in special machines, it takes about an hour to perform, and samples must typically be sent away to a lab.

The team of scientists devised a postage stamp-sized polydimethylsiloxane chip with a microchamber array for the PCR reactions.

They tested the device on a piece of DNA containing a SARS-CoV-2 gene, accomplishing 40 heating and cooling cycles and fluorescence detection in five minutes, with an additional three minutes for sample loading.

The amplification efficiency was 91%, whereas a comparable conventional PCR process has an efficiency of 98%.

The new device could provide many opportunities for rapid point-of-care diagnostics during a pandemic, the researchers say.

bit.ly/2Sq6U6C

Image credit | Korea Advanced Institute of Science and Technology(KAIST)

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top